Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Antibiotic Quagmire Demands Creativity
Effectively Evading Bacterial Resistance Requires a Combination of Old and New Strategies
- While novel antibiotics are critically needed, some researchers say that there aren’t a whole lot of new bacterial targets to aim at. New antibiotics may mean enhancing old ones to evade bacterial resistance mechanisms. An article published last year by The New England Journal of Medicine pointed out, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.